42 CFR 8, Subpart C - Procedures for Review of Suspension or Proposed Revocation of OTP Certification, and of Adverse Action Regarding Withdrawal of Approval of an Accreditation Body
- § 8.21 — Applicability.
- § 8.22 — Definitions.
- § 8.23 — Limitation on issues subject to review.
- § 8.24 — Specifying who represents the parties.
- § 8.25 — Informal review and the reviewing official's response.
- § 8.26 — Preparation of the review file and written arguments.
- § 8.27 — Opportunity for oral presentation.
- § 8.28 — Expedited procedures for review of immediate suspension.
- § 8.29 — Ex parte communications.
- § 8.30 — Transmission of written communications by reviewing official and calculation of deadlines.
- § 8.31 — Authority and responsibilities of the reviewing official.
- § 8.32 — Administrative record.
- § 8.33 — Written decision.
- § 8.34 — Court review of final administrative action; exhaustion of administrative remedies.
Title 42 published on 2012-10-01
The following are only the Rules published in the Federal Register after the published date of Title 42.
For a complete list of all Rules, Proposed Rules, and Notices view the Rulemaking tab.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.
This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].
It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.
§ 823 - Registration requirements
§ 257a - Transferred
§ 290aa - Substance Abuse and Mental Health Services Administration
42 USC § 290dd–2 - Confidentiality of records
42 USC § 300x–23 - Intravenous substance abuse
42 USC § 300x–27 - Treatment services for pregnant women
42 USC § 300y–11 - Interim maintenance treatment
Title 42 published on 2012-10-01
The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 42 CFR 8 after this date.
GPO FDSys XML | Text type regulations.gov FR Doc. 2012-29417 RIN 0930-AA14 DEPARTMENT OF HEALTH AND HUMAN SERVICES, Substance Abuse and Mental Health Services Administration (SAMHSA) Final rule. This rule is effective January 7, 2013. 42 CFR Part 8 This final rule amends the federal opioid treatment program regulations by modifying the dispensing requirements for buprenorphine and buprenorphine combination products approved by the Food and Drug Administration (FDA) for opioid dependence and used in federally certified and registered opioid treatment programs. In particular, this rule would allow opioid treatment programs more flexibility in dispensing take-home supplies of buprenorphine—removing restrictions on the time a patient needs to be in treatment in order to receive take-home supplies—after the assessment and documentation of a patient's responsibility and stability to receive opioid addiction treatment medication. Opioid treatment programs that use these products in the treatment of opioid dependence will continue to adhere to all other federal treatment standards established for methadone.